/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

NeoGenomics, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$11.99 0.0041(0.41%) NEO at 04 Dec 2025 04:39 PM Diagnostics & Research
Lowest Today 11.96
Highest Today 12.2
Today’s Open 12.2
Prev. Close 12.07
52 Week High 19.12
52 Week Low 4.72
Day’s Range: Low 11.96 High 12.2
52-Week Range: Low 4.72 High 19.12
1 day return -
1 Week return +0.08
1 month return +20.0
3 month return +50.31
6 month return +64.04
1 year return -32.69
3 year return +2.62
5 year return -74.76
10 year return -

Institutional Holdings

BlackRock Inc 15.04

Vanguard Group Inc 10.94

iShares Core S&P Small-Cap ETF 5.93

Greenhouse Funds LLLP 5.75

First Light Asset Management, LLC 5.30

State Street Corp 3.96

Macquarie Group Ltd 3.72

Dimensional Fund Advisors, Inc. 3.32

Vanguard Total Stock Mkt Idx Inv 3.12

Schroder Investment Management Group 2.88

Macquarie Small Cap Core I 2.79

American Century Companies Inc 2.72

Millennium Management LLC 2.57

T. Rowe Price Investment Management,Inc. 2.52

Geode Capital Management, LLC 2.44

Vanguard Small Cap Index 2.42

iShares Russell 2000 ETF 2.39

American Century Small Cap Growth Inv 2.13

American Century U.S. Small Cap Growth 2.13

Morgan Stanley - Brokerage Accounts 1.93

GW&K Investment Management, LLC 1.92

Segall Bryant & Hamill 1.83

Deerfield Management Co 1.66

HHG PLC 1.55

Vanguard Small Cap Growth Index Inv 1.35

Jennison Associates LLC 1.29

Bank of America Corp 1.16

Goldman Sachs Group Inc 1.15

Vanguard Institutional Extnd Mkt Idx Tr 1.07

Franklin US Small Cap Growth Equity 1.05

Janus Henderson US Small Cap Growth 1.01

Janus Henderson Venture D 1.01

Fidelity Small Cap Index 1.00

Franklin Small Cap Growth Adv 0.97

T. Rowe Price US Small-Cap Core Equity 0.92

SPDR® Portfolio S&P 600™ Sm Cap ETF 0.88

iShares Russell 2000 Value ETF 0.80

Glenmede Small Cap Equity 0.76

Glenmede Small Cap Equity Adv 0.76

Schroder US Smaller Companies Acc 0.69

Market Status

Strong Buy: 6

Buy: 2

Hold: 6

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 1561.71 M

PB Ratio 1.8553

PE Ratio 0.0

Enterprise Value 1801.43 M

Total Assets 1638.04 M

Volume 1396008

Company Financials

Annual Revenue FY24:660566000 660.6M, FY23:591643000 591.6M, FY22:509728000 509.7M, FY21:484329000 484.3M, FY20:444448000 444.4M

Annual Profit FY24:290100000 290.1M, FY23:244604000 244.6M, FY22:187896000 187.9M, FY21:187060000 187.1M, FY20:185893000 185.9M

Annual Net worth FY24:-78726000 -78.7M, FY23:-87968000 -88.0M, FY22:-144250000 -144.3M, FY21:-8347000 -8.3M, FY20:4172000 4.2M

Quarterly Revenue Q3/2025:187797000 187.8M, Q2/2025:181330000 181.3M, Q1/2025:168035000 168.0M, Q4/2024:172000000 172.0M, Q3/2024:167824000 167.8M

Quarterly Profit Q3/2025:80446000 80.4M, Q2/2025:77258000 77.3M, Q1/2025:73246000 73.2M, Q4/2024:77257000 77.3M, Q3/2024:74880000 74.9M

Quarterly Net worth Q3/2025:-27129000 -27.1M, Q2/2025:-45092000 -45.1M, Q1/2025:-25923000 -25.9M, Q4/2024:-15324000 -15.3M, Q3/2024:-17699000 -17.7M

Fund house & investment objective

Company Information NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Organisation Diagnostics & Research

Employees 2200

Industry Diagnostics & Research

CEO Mr. Anthony P. Zook

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow